加拿大成人肥胖临床实践指南中的医学化驱动因素。
Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.
机构信息
Department of Sociology, University of New Brunswick, 3 Bailey Drive, P.O. Box 4400, Fredericton, New Brunswick, E3B 5A3, Canada.
Flourish Kirribilli, 13/1 Broughton St, Kirribilli, NSW, 2061, Australia.
出版信息
Can J Public Health. 2022 Oct;113(5):743-748. doi: 10.17269/s41997-022-00662-4. Epub 2022 Jul 15.
Abstract
The new Canadian Adult Obesity Clinical Practice Guidelines frame higher body weight as a chronic, relapsing disease requiring comprehensive medical treatment pathways. In this commentary, we will demonstrate how a process called pharmaceuticalization is informing the new guidelines. We join those questioning the normalization of industry and medical collaboration and interrogate whether the new guidelines meaningfully address stigma.
摘要
新的加拿大成人肥胖临床实践指南将较高的体重定义为一种需要全面医疗治疗途径的慢性、复发性疾病。在这篇评论中，我们将展示制药化过程如何为新指南提供信息。我们加入了那些对行业和医疗合作正常化提出质疑的人，并探讨新指南是否真正解决了耻辱问题。
相似文献
1
Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.
Can J Public Health. 2022 Oct;113(5):743-748. doi: 10.17269/s41997-022-00662-4. Epub 2022 Jul 15.
2
Fatness, medicalization, and stigma: on the need to do better.
Narrat Inq Bioeth. 2014 Summer;4(2):117-23. doi: 10.1353/nib.2014.0053.
3
The 'side effects' of medicalization: a meta-analytic review of how biogenetic explanations affect stigma.
Clin Psychol Rev. 2013 Aug;33(6):782-94. doi: 10.1016/j.cpr.2013.06.002. Epub 2013 Jun 18.
4
Risk factor medicalization, hubris, and the obesity disease.
Narrat Inq Bioeth. 2014 Summer;4(2):143-6. doi: 10.1353/nib.2014.0043.
5
Obesity Prevention and Management Strategies in Canada: Shifting Paradigms and Putting People First.
Curr Obes Rep. 2018 Jun;7(2):89-96. doi: 10.1007/s13679-018-0309-8.
6
Inequities in healthcare: a review of bias and discrimination in obesity treatment.
Can J Diabetes. 2013 Jun;37(3):205-9. doi: 10.1016/j.jcjd.2013.03.362. Epub 2013 May 29.
7
Discrimination in the health care system among higher-weight adults: evidence from a Canadian national cross-sectional survey.
Health Promot Chronic Dis Prev Can. 2020 Nov/Dec;40(11-12):329-335. doi: 10.24095/hpcdp.40.11/12.01.
8
Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization.
Br J Clin Pharmacol. 2022 Jan;88(1):34-39. doi: 10.1111/bcp.14835. Epub 2021 Mar 31.
9
Canadian Senate Report on Obesity: Focusing on Individual Behaviours versus Social Determinants of Health May Promote Weight Stigma.
J Obes. 2018 Jul 2;2018:8645694. doi: 10.1155/2018/8645694. eCollection 2018.
10
The Incomplete Medicalization of Obesity: Physician Office Visits, Diagnoses, and Treatments, 1996-2014.
Public Health Rep. 2019 Mar/Apr;134(2):141-149. doi: 10.1177/0033354918813102. Epub 2019 Feb 22.
本文引用的文献
1
Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.
J Bioeth Inq. 2021 Sep;18(3):477-497. doi: 10.1007/s11673-021-10119-x. Epub 2021 Sep 6.
2
Treatment Outcomes and Trajectories of Change in Patients Attributing Their Eating Disorder Onset to Anti-obesity Messaging.
Psychosom Med. 2021 Sep 1;83(7):777-786. doi: 10.1097/PSY.0000000000000962.
3
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.
J Gen Intern Med. 2021 Oct;36(10):3194-3198. doi: 10.1007/s11606-021-06657-0. Epub 2021 Mar 10.
4
Benefits and Risks of Bariatric Surgery in Adults: A Review.
JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567.
5
Obesity in adults: a clinical practice guideline.
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
6
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
CMAJ. 2020 Jun 8;192(23):E617-E625. doi: 10.1503/cmaj.191737.
7
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - .
Endocr Pract. 2020 Jan;26(1):107-139. doi: 10.4158/CS-2019-0472.
8
A critical analysis of obesity prevention policies and strategies.
Can J Public Health. 2017 Sep;108(5-6):e598-e608. doi: 10.17269/CJPH.108.6044. Epub 2017 Sep 1.
9
Knowledge brokering: (mis)aligning population knowledge with care of fat bodies.
Can J Public Health. 2018 Dec;109(5-6):643-652. doi: 10.17269/s41997-018-0147-1. Epub 2018 Nov 21.
10
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.
Am J Public Health. 2018 Nov;108(11):e9-e16. doi: 10.2105/AJPH.2018.304677. Epub 2018 Sep 25.
Zotero 插件